Company Filing History:
Years Active: 2021-2025
Title: Innovations by Edgar B Francisco
Introduction
Edgar B Francisco is a notable inventor based in San Carlos, California. He has made significant contributions to the field of medical technology, particularly in relation to COVID-19 treatment and assessment. With a total of five patents to his name, Francisco's work is at the forefront of innovative healthcare solutions.
Latest Patents
One of his latest patents involves methods of assigning a COVID pathological type based on a cytokine/chemokine panel. This patent provides methods for determining a COVID pathological type for subjects suffering from COVID-19 by utilizing a quantitative, multiplex cytokine/chemokine panel from test samples. Additionally, it includes methods for treating long hauler subjects by administering a CCR5/CCL5 interaction inhibitor. Another significant patent focuses on treating hypercytokinemia by administering the CCR5/CCL5 interaction inhibitor maraviroc. This method assesses the severity of diseases involving hypercytokinemia, such as COVID-19, by determining the level of CCL5/RANTES in a subject.
Career Highlights
Edgar B Francisco is currently associated with Incelldx, Inc., where he continues to innovate in the medical field. His work has been instrumental in developing therapies that address the complexities of COVID-19 and its long-term effects.
Collaborations
Francisco collaborates with notable colleagues, including Amruta Pise and Bruce K Patterson, who contribute to the research and development of his innovative methods and treatments.
Conclusion
Edgar B Francisco's contributions to medical technology, particularly in the context of COVID-19, highlight his role as a leading inventor in the field. His patents reflect a commitment to improving patient care and treatment outcomes.